Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Optimal management of β thalassaemia intermedia.

British journal of haematology - 1 Mar 2011

Taher Ali T, Musallam Khaled M, Cappellini Maria Domenica, Weatherall David J

Abstract excerpt

Our understanding of the molecular and pathophysiological mechanisms underlying the disease process in patients with β thalassaemia intermedia (TI) has substantially increased over the past decade. The hallmark of disease process in patients with TI includes ineffective erythropoiesis, chronic haemolytic anaemia, and iron overload. There are a number of options currently available for managing patients with TI...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Genotype
Share to Iron Chelating Agents
Share to Phenotype

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Splenectomy

Share to beta-Thalassemia

Share to Blood Transfusion

Share to Fetal Hemoglobin

Source

Identifiers

PMID: 21250971
DOI: 10.1111/j.1365-2141.2010.08486.x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Optimal management of β thalassaemia intermedia.PMID 21250971Read ↗

A paradigm shift on beta-thalassaemia treatment: How will we manage this old disease with new therapies?Semantic proximity Read ↗

Ineffective Erythropoiesis in β-Thalassaemia: Key Steps and Therapeutic Options by Drugs.Semantic proximity Read ↗

Insight onto the pathophysiology and clinical complications of thalassemia intermedia.Semantic proximity Read ↗

Hb E/beta-thalassaemia: a common & clinically diverse disorder.Semantic proximity Read ↗

Beta thalassemia syndromes: New insightsSemantic proximity Read ↗

New Insights Into Pathophysiology of β-ThalassemiaSemantic proximity Read ↗

Novel therapies in β‐thalassaemiaSemantic proximity Read ↗

Pathophysiology and treatment of patients with beta-thalassemia – an updateSemantic proximity Read ↗

Understanding the Intricacies of Iron Overload Associated With β-Thalassemia: A Comprehensive ReviewSemantic proximity Read ↗

Current Perspective of Beta Thalassemia and Its Treatment StrategiesSemantic proximity Read ↗

Current status of beta-thalassemia and its treatment strategies.Semantic proximity Read ↗

Pathophysiology and Clinical Manifestations of the β-Thalassemias.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.